The FDA has issued a warning letter to Novo Nordisk for violating postmarketing adverse drug experience regulations that include failure to report adverse events among patients taking GLP-1s. Chronic ...
The Vantage NXT system provides three encoder inputs that enable users to track position, movement, and rotation during data acquisition. Researchers can use encoder count data for Pulse-on-position ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results